An Analysis of microRNA Expression in the Myelodysplastic Syndromes Using Hematopoietic Stem Cells

Abstract

We utilized primary bone marrow specimens from patients with the myelodysplastic syndromes(MDS) to identify microRNAs (miRNAs) dysregulated in MDS hematopoietic stem cells (MDS HSCs)as compared with normal HSCs. MiRNAs differentially expressed between MDS HSCs and normalHSCs overlapped significantly with those differentially expressed between HSCs from old andyoung normal patients, suggesting that MDS pathogenesis may overlap significantly with thatof normal aging. A miRNA significantly downregulated in normal older HSCs that was furtherdownregulated in MDS was miR-125b. We examined old and young mice to confirm that miR-125b isalso downregulated in older mice, and studies reintroducing miR-125b into old HSCs restoredtheir long-term reconstitution capacity and self-renewal as demonstrated by serialtransplantation assays. Together, these findings validate the functional role of miR-125b inhematopoiesis in the context of aging and its likely implication in the age-relatedpredisposition for the development of MDS.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2015
Accession Number
AD1006992

Entities

People

  • Stephen Chung

Organizations

  • Sloan-Kettering Institute

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Blood
  • Bone Marrow
  • Bone Marrow Cells
  • Bones
  • Cancer
  • Cells
  • Diseases And Disorders
  • Hematologic Diseases
  • Hematopoiesis
  • Leukemia
  • Lymphatic Diseases
  • Neoplasms
  • Pathogenesis
  • Stem Cells
  • Transplantation

Fields of Study

  • Biology

Readers

  • Immunology and Pathology
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology